Virginia Tech Cancer Research Alliance

Two million people in the United States alone are projected to be diagnosed with cancer in 2023. More than a half million will die. Investigators from Virginia Tech, its clinical partner Children’s National Hospital, and other institutions gathered on the Children’s National Research & Innovation Campus in Washington, D.C.,  in May to foster collaboration to combat the deadly disease.

Speakers, a mix of scientists and physicians conducting clinical trials, described innovative therapy types, fresh biological targets, and new technologies in the hopes of fostering collaborations between scientists and institutions.

“This type of interdisciplinary collaborative science that eschews administrative and disciplinary boundaries is at the heart of what Virginia Tech is about," said Michael Friedlander, executive director of the Fralin Biomedical Research Institute at VTC, Virginia Tech’s vice president for health sciences and technology, and founder of the Cancer Research Alliance.